Role of MicroRNAs in Immune Regulation and Pathogenesis of Chlamydia Trachomatis and Chlamydia Muridarum Infections: a Rapid Review

Overview

Journal Microbes Infect

Publisher Elsevier

Specialties Allergy & Immunology
Microbiology

Date 2024 Jul 18

PMID 39025257

Authors

Chloe Meewes

Kanupriya Gupta

William M Geisler

Affiliations

Soon will be listed here.

Abstract

MicroRNAs in Chlamydia trachomatis (CT) and Chlamydia muridarum (CM) infections are an emerging topic of research that provide knowledge that could advance vaccine development and strategies for managing infection. This rapid review summarizes human and murine studies on miRNA expression in CT and CM infections in vivo and ex vivo.

References

Tang W, Mao J, Li K, Walker J, Chou R, Fu R . Pregnancy and fertility-related adverse outcomes associated with infection: a global systematic review and meta-analysis. Sex Transm Infect. 2019; 96(5):322-329. PMC: 7292777. DOI: 10.1136/sextrans-2019-053999. View

Ling H, Luo L, Dai X, Chen H . Fallopian tubal infertility: the result of Chlamydia trachomatis-induced fallopian tubal fibrosis. Mol Cell Biochem. 2021; 477(1):205-212. DOI: 10.1007/s11010-021-04270-7. View

Igietseme J, Omosun Y, Partin J, Goldstein J, He Q, Joseph K . Prevention of Chlamydia-induced infertility by inhibition of local caspase activity. J Infect Dis. 2013; 207(7):1095-104. PMC: 3583275. DOI: 10.1093/infdis/jit009. View

Solomon A, Burton M, Gower E, Harding-Esch E, Oldenburg C, Taylor H . Trachoma. Nat Rev Dis Primers. 2022; 8(1):32. DOI: 10.1038/s41572-022-00359-5. View

Gupta R, Arkatkar T, Keck J, Koundinya G, Castillo K, Hobel S . Antigen specific immune response in Chlamydia muridarum genital infection is dependent on murine microRNAs-155 and -182. Oncotarget. 2016; 7(40):64726-64742. PMC: 5323111. DOI: 10.18632/oncotarget.11461. View

Kothari A, Mi Z, Zapf M, Kuo P . Novel clinical therapeutics targeting the epithelial to mesenchymal transition. Clin Transl Med. 2014; 3:35. PMC: 4198571. DOI: 10.1186/s40169-014-0035-0. View

Lundy S, Abney K, Ellerson D, Igietseme J, Carroll D, Eko F . MiR-378b Modulates -Induced Upper Genital Tract Pathology. Pathogens. 2021; 10(5). PMC: 8151610. DOI: 10.3390/pathogens10050566. View

OBrien J, Hayder H, Zayed Y, Peng C . Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation. Front Endocrinol (Lausanne). 2018; 9:402. PMC: 6085463. DOI: 10.3389/fendo.2018.00402. View

Abraham S, Juel H, Bang P, Cheeseman H, Dohn R, Cole T . Safety and immunogenicity of the chlamydia vaccine candidate CTH522 adjuvanted with CAF01 liposomes or aluminium hydroxide: a first-in-human, randomised, double-blind, placebo-controlled, phase 1 trial. Lancet Infect Dis. 2019; 19(10):1091-1100. DOI: 10.1016/S1473-3099(19)30279-8. View

10.

Igietseme J, Omosun Y, Stuchlik O, Reed M, Partin J, He Q . Role of Epithelial-Mesenchyme Transition in Chlamydia Pathogenesis. PLoS One. 2015; 10(12):e0145198. PMC: 4683008. DOI: 10.1371/journal.pone.0145198. View

11.

Derrick T, Last A, Burr S, Roberts C, Nabicassa M, Cassama E . Inverse relationship between microRNA-155 and -184 expression with increasing conjunctival inflammation during ocular Chlamydia trachomatis infection. BMC Infect Dis. 2016; 16:60. PMC: 4739388. DOI: 10.1186/s12879-016-1367-8. View

12.

Bakshi R, Gupta K, Jordan S, Chi X, Lensing S, Press C . An Adaptive -Specific IFN-γ-Producing CD4 T Cell Response Is Associated With Protection Against Chlamydia Reinfection in Women. Front Immunol. 2018; 9:1981. PMC: 6137090. DOI: 10.3389/fimmu.2018.01981. View

13.

Kimura M, Kothari S, Gohir W, Camargo J, Husain S . MicroRNAs in infectious diseases: potential diagnostic biomarkers and therapeutic targets. Clin Microbiol Rev. 2023; 36(4):e0001523. PMC: 10732047. DOI: 10.1128/cmr.00015-23. View

14.

Yeruva L, Myers G, Spencer N, Creasy H, Adams N, Maurelli A . Early microRNA expression profile as a prognostic biomarker for the development of pelvic inflammatory disease in a mouse model of chlamydial genital infection. mBio. 2014; 5(3):e01241-14. PMC: 4073489. DOI: 10.1128/mBio.01241-14. View

15.

De Clercq E, Kalmar I, Vanrompay D . Animal models for studying female genital tract infection with Chlamydia trachomatis. Infect Immun. 2013; 81(9):3060-7. PMC: 3754237. DOI: 10.1128/IAI.00357-13. View

16.

Batteiger T, Spencer N, Washam C, Byrum S, Eledge M, Batteiger B . Endocervical miRNA Expression Profiles in Women Positive for Chlamydia trachomatis with Clinical Signs and/or Symptoms Are Distinct from Those in Women Positive for Chlamydia trachomatis without Signs and Symptoms. Infect Immun. 2020; 88(10). PMC: 7504953. DOI: 10.1128/IAI.00057-20. View

17.

Redgrove K, McLaughlin E . The Role of the Immune Response in Chlamydia trachomatis Infection of the Male Genital Tract: A Double-Edged Sword. Front Immunol. 2014; 5:534. PMC: 4209867. DOI: 10.3389/fimmu.2014.00534. View

18.

Wang W, Stassen F, Surcel H, Ohman H, Tiitinen A, Paavonen J . Analyses of polymorphisms in the inflammasome-associated NLRP3 and miRNA-146A genes in the susceptibility to and tubal pathology of Chlamydia trachomatis infection. Drugs Today (Barc). 2009; 45 Suppl B:95-103. View

19.

Yeruva L, Pouncey D, Eledge M, Bhattacharya S, Luo C, Weatherford E . MicroRNAs Modulate Pathogenesis Resulting from Chlamydial Infection in Mice. Infect Immun. 2016; 85(1). PMC: 5203655. DOI: 10.1128/IAI.00768-16. View

20.

Gupta R, Arkatkar T, Yu J, Wali S, Haskins W, Chambers J . Chlamydia muridarum infection associated host MicroRNAs in the murine genital tract and contribution to generation of host immune response. Am J Reprod Immunol. 2014; 73(2):126-40. PMC: 4357020. DOI: 10.1111/aji.12281. View